2022

1. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

   JCI Insight, Vol. 7, Núm. 7

2. Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma

   Molecular Therapy - Oncolytics, Vol. 26, pp. 246-264

3. Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory

   Molecular Cancer Therapeutics, Vol. 21, Núm. 3, pp. 471-480